Our medical innovation system is in jeopardy. Investment in life science area is declining at an alarming rate because of the escalating cost, time and risk of developing new drugs and devices.
Joe Pitts: “Our medical innovation system is in jeopardy. Investment in life science area is declining at an alarming rate because…”
On the recordFebruary 14, 2012
Source
congress.govEditor's note · Context
Pitts highlights concerns over declining investment in medical innovation due to regulatory issues.
Share
More from Joe Pitts
Dec 6, 2016
Explicitly creating a program exclusively for catfish seems to be unnecessary, and it directs resources away from high-risk foods.
Sep 13, 2016
It is unfortunate that we have a Congress of the United States, the majority parties that want to just tear down this law.
Sep 13, 2016
It is embarrassing that in the most capable country in the world, in the most powerful elected bodies in the world that we effectively have done almost nothing to improve the health care of Americans since this law has been passed.
Dec 6, 2016
The jurisdictional grab serves only to shield catfish farmers against competition at the expense of U.S. consumers.





